Opus Genetics, Inc.
IRD· Nasdaq
IRDOpus Genetics, Inc.
Filed Nov 3, 2017 · 10-Q · 34 days after period end · 0001140361-17-040967
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Net Income | -$1.04M | -$2.87M | -$4.03M | -$1.91M |
| EPS Diluted | -$0.04 | -$0.13 | -$0.02 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Opus Genetics, Inc. · CIK 1228627 · Engraved from SEC EDGAR
ended Sep 30, 2017 · filed Nov 3, 2017 · 34 d after period end
